110 related articles for article (PubMed ID: 3759735)
1. Enhanced bactericidal action of mouse macrophages by subinhibitory concentrations of monobactams.
Iida-Tanaka K; Tanaka T; Irino S; Nagayama A
J Antimicrob Chemother; 1986 Aug; 18(2):239-50. PubMed ID: 3759735
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of monobactams as antibacterial agents against gram-negative bacteria.
Fu HG; Hu XX; Li CR; Li YH; Wang YX; Jiang JD; Bi CW; Tang S; You XF; Song DQ
Eur J Med Chem; 2016 Mar; 110():151-63. PubMed ID: 26827160
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
4. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
Saionji K
Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
Nakao M; Kondo M; Imada A
J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
[TBL] [Abstract][Full Text] [Related]
6. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
Pruul H; Lewis G; McDonald PJ
J Antimicrob Chemother; 1988 Nov; 22(5):675-86. PubMed ID: 3209526
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion.
Burgess DS; Summers KK; Hardin TC
Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260
[TBL] [Abstract][Full Text] [Related]
8. Immunization of mice with antibiotic treated Escherichia coli.
Raponi G; Nazzari G; Lun MT; Lorino G; Valentini T; Bronzini M; Gaeta A; Mancini C; Filadoro F
J Chemother; 1991 Jan; 3 Suppl 1():136-40. PubMed ID: 12041748
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
10. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
12. In-vitro antibacterial activity of BO-1165, a new monobactam antibiotic.
Matsuda K; Nagashima M; Nakagawa S; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1986 Jun; 17(6):747-53. PubMed ID: 3525497
[TBL] [Abstract][Full Text] [Related]
13. Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):85-94. PubMed ID: 3518296
[TBL] [Abstract][Full Text] [Related]
14. The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam.
Jones RN; Barry AL; Thornsberry C; Fuchs PC; Packer RR
Am J Clin Pathol; 1986 Nov; 86(5):608-18. PubMed ID: 3096130
[TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
16. In vitro effects of monobactams on Legionella pneumophila.
Yoshida S; Mizuguchi Y; Nikaido Y
J UOEH; 1987 Sep; 9(3):299-303. PubMed ID: 3685714
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
Qadri SM; Belobraydic KA
Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
[TBL] [Abstract][Full Text] [Related]
19. [Combined antibacterial activity of aztreonam and clindamycin against clinically isolated strains].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 May; 44(5):529-37. PubMed ID: 1880932
[TBL] [Abstract][Full Text] [Related]
20. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
